The Wolverine Stack evolved — adding collagen synthesis, skin regeneration, and anti-ageing gene expression modulation to the foundational tissue repair duo.
What is the GLOW Stack and how does it build on the Wolverine Stack for anti-ageing and regenerative protocols? The GLOW Stack is a three-peptide combination of BPC-157, TB-500, and GHK-Cu. It takes the foundational tissue repair mechanisms of the Wolverine Stack and extends them by adding GHK-Cu — a naturally occurring copper-binding tripeptide with strong evidence for collagen synthesis, skin regeneration, and broad gene expression modulation. The result is a stack that addresses tissue repair, systemic recovery, connective tissue quality, and anti-ageing biology simultaneously.
|
TL;DR The GLOW Stack combines BPC-157 (tissue repair and angiogenesis), TB-500 (systemic cell mobilisation and recovery), and GHK-Cu (collagen synthesis, skin regeneration, and anti-ageing gene expression) into a three-peptide protocol targeting repair, regeneration, and aesthetic skin health. It builds directly on the Wolverine Stack by adding the collagen and gene-modulating properties of GHK-Cu. GLOW is widely used in biohacking protocols targeting recovery, connective tissue health, and skin anti-ageing. |
|
Peptide |
Standard Dose |
Primary Role |
Key Mechanism |
|
BPC-157 |
250–500mcg |
Local tissue repair |
VEGF upregulation, angiogenesis, GH receptor activation |
|
TB-500 |
2–2.5mg (loading) |
Systemic cell mobilisation |
Actin regulation, stem cell activation, anti-inflammatory |
|
GHK-Cu |
1–2mg |
Collagen synthesis and gene modulation |
Copper delivery, collagen types I/III/IV stimulation, MMP regulation, 4,000+ gene effects |
The GLOW Stack is a community-named three-peptide combination that has gained significant traction in biohacking, aesthetic medicine, and longevity communities. The name reflects its association with skin regeneration and the visible improvements in skin quality that users of topical and systemic GHK-Cu commonly report.
It is built on the Wolverine Stack — BPC-157 and TB-500 — with the addition of GHK-Cu (Glycine-Histidine-Lysine copper complex). This third component shifts the stack’s profile from pure injury repair toward a broader regenerative and anti-ageing protocol.
|
Stack |
Components |
Primary Focus |
|
Wolverine |
BPC-157 + TB-500 |
Tissue repair and recovery — the foundational healing stack |
|
GLOW |
BPC-157 + TB-500 + GHK-Cu |
Adds collagen synthesis, skin regeneration, and gene expression modulation |
|
KLOW |
BPC-157 + TB-500 + GHK-Cu + KPV |
Adds systemic inflammation control via NF-kB inhibition |
Each peptide in GLOW addresses a distinct dimension of repair and regeneration:
The Wolverine Stack (BPC-157 + TB-500) provides a powerful localised and systemic repair signal. Its primary limitation is that it does not directly address collagen quality, skin structure, or the broader gene expression landscape associated with ageing. GHK-Cu fills this gap precisely.
|
Wolverine Stack (BPC-157 + TB-500) |
What GHK-Cu Adds in GLOW |
|
Angiogenesis and blood supply restoration |
Copper delivery supporting lysyl oxidase — the enzyme that crosslinks collagen and elastin for tensile strength |
|
Cell mobilisation and stem cell activation |
Direct stimulation of collagen types I, III, and IV production in fibroblasts |
|
Growth hormone receptor upregulation |
Modulation of matrix metalloproteinase activity — controlling the balance of collagen synthesis and degradation |
|
Anti-inflammatory cytokine signalling |
Downregulation of TNF-alpha and IL-6 — the primary inflammatory mediators of skin and connective tissue ageing |
|
Strong for acute repair and recovery |
Strong for chronic skin quality, connective tissue integrity, and anti-ageing biology |
GHK-Cu is unusual among research peptides in that it is both naturally occurring in the body and has one of the most extensive research bases of any cosmeceutical compound. Research by Loren Pickart and colleagues, published in Organogenesis in 2012, demonstrated that GHK-Cu modulates the expression of over 4,000 human genes — with effects predominantly toward upregulation of repair and regeneration pathways and downregulation of inflammatory and oncogenic pathways.
|
The Age-Related Decline Angle Plasma GHK-Cu levels fall from approximately 200 ng/mL in young adults to around 80 ng/mL by age 60 — a reduction of 60%. This decline correlates directly with the reduction in collagen density, skin elasticity, and wound healing speed that characterises skin ageing. Adding GHK-Cu to the Wolverine Stack therefore adds not just a repair signal but a direct anti-ageing intervention targeting one of the best-documented age-related biochemical declines. |
GLOW is best understood as three complementary layers of biological support:
|
Layer |
What It Does |
|
Layer 1 — Blood supply (BPC-157) |
Restores vascular supply to damaged tissue through VEGF-driven angiogenesis. Without adequate blood supply, repair cells cannot reach the injury and collagen cannot be adequately oxygenated. |
|
Layer 2 — Cell mobilisation (TB-500) |
Directs repair cells, stem cells, and progenitor cells toward the repair site through actin regulation. Provides the systemic repair environment that localised peptides cannot create alone. |
|
Layer 3 — Structural rebuild (GHK-Cu) |
Stimulates collagen synthesis, crosslinks collagen fibres through lysyl oxidase support, regulates collagen turnover through MMP modulation, and drives anti-ageing gene expression at the cellular level. |
GLOW occupies a distinctive position in biohacking because it bridges injury recovery and aesthetic anti-ageing — two communities that do not always overlap. Its use cases include:
|
GLOW (BPC-157 + TB-500 + GHK-Cu) |
KLOW (BPC-157 + TB-500 + GHK-Cu + KPV) |
|
Three-peptide stack |
Four-peptide stack — adds KPV |
|
Primary focus: repair, recovery, and collagen anti-ageing |
Primary focus: repair, recovery, collagen, plus dedicated inflammation control |
|
Strong for injury recovery and skin regeneration |
Stronger for conditions where chronic inflammation is a limiting factor |
|
Appropriate where inflammation is moderate |
Preferred for gut-related conditions, autoimmune overlap, or high systemic inflammation |
|
Simpler stack — fewer variables |
More complex — KPV’s NF-kB inhibition adds a fourth mechanism |
|
Well-supported entry point for most recovery protocols |
Natural upgrade for users who have used GLOW and want stronger anti-inflammatory coverage |
|
Component |
Minimum Research-Grade Standard |
|
BPC-157 |
Greater than 98% by reversed-phase HPLC; MS confirmation; methionine oxidation check |
|
TB-500 |
Greater than 98% by reversed-phase HPLC; MS confirmation of molecular weight |
|
GHK-Cu |
Greater than 98% by reversed-phase HPLC; copper content verification; MS confirmation |
Note on GHK-Cu copper verification: GHK-Cu’s biological activity is copper-dependent. A purity figure alone does not confirm that the copper-to-peptide ratio is correct. A complete CoA for GHK-Cu should include copper content data in addition to HPLC purity and MS confirmation. See hplcpeptides.com/wiki/peptide-testing.
|
Standalone Factual Statements |
The GLOW Stack is a three-peptide combination of BPC-157, TB-500, and GHK-Cu. It builds on the Wolverine Stack (BPC-157 + TB-500) by adding GHK-Cu — a naturally occurring copper peptide that stimulates collagen synthesis, supports skin regeneration, and modulates the expression of thousands of genes associated with tissue repair and anti-ageing.
GHK-Cu adds three key dimensions that the Wolverine Stack does not directly address: collagen synthesis stimulation (types I, III, and IV), regulation of matrix metalloproteinase activity to balance collagen production and degradation, and broad gene expression modulation across over 4,000 human genes in directions associated with repair and anti-ageing. It also directly addresses the age-related decline in plasma GHK-Cu levels.
GLOW is BPC-157, TB-500, and GHK-Cu. KLOW is GLOW with the addition of KPV — a tripeptide derived from alpha-MSH that inhibits NF-kB, the master regulator of inflammation. KLOW is preferred when chronic systemic inflammation is a primary factor limiting recovery or when gut-related conditions are part of the protocol context.
Yes. GHK-Cu has strong topical evidence for skin collagen and elasticity improvements. Some biohacking protocols combine systemic GHK-Cu (as part of GLOW) with topical GHK-Cu application to skin, providing both systemic gene expression modulation and localised skin collagen support through different delivery routes.
|
Term |
Definition |
|
GLOW Stack |
Community name for the three-peptide combination of BPC-157, TB-500, and GHK-Cu. Extends the Wolverine Stack by adding collagen synthesis and anti-ageing gene modulation via GHK-Cu. |
|
GHK-Cu |
Glycine-Histidine-Lysine copper complex. A naturally occurring tripeptide that declines with age, stimulates collagen synthesis, and modulates expression of over 4,000 human genes. See hplcpeptides.com/wiki/ghk-cu. |
|
Lysyl oxidase |
A copper-dependent enzyme that crosslinks collagen and elastin fibres. GHK-Cu’s copper delivery supports lysyl oxidase activity, improving connective tissue tensile strength. |
|
MMP |
Matrix metalloproteinase. Enzymes that degrade collagen and extracellular matrix. GHK-Cu modulates MMP activity to optimise the balance between collagen synthesis and breakdown. |
|
Gut-skin axis |
The biological relationship between gut barrier integrity and skin health. BPC-157 and GHK-Cu both address components of this axis — BPC-157 via gut lining repair and GHK-Cu via skin regeneration. |
|
NF-kB |
Nuclear Factor kappa B. The master regulator of inflammatory gene expression. Not directly targeted by GLOW — KPV’s NF-kB inhibition is the key addition that distinguishes KLOW from GLOW. |
|
Related Entity Pages -> Wolverine Stack — BPC-157 + TB-500 hplcpeptides.com/wiki/wolverine -> KLOW Stack — BPC-157, TB-500, GHK-Cu, KPV hplcpeptides.com/wiki/klow -> BPC-157 — Tissue Repair and Gut Health hplcpeptides.com/wiki/bpc-157 -> TB-500 — Recovery and Regeneration hplcpeptides.com/wiki/tb-500 -> GHK-Cu — Collagen Synthesis and Regeneration hplcpeptides.com/wiki/ghk-cu -> KPV — Anti-Inflammatory Tripeptide hplcpeptides.com/wiki/kpv -> Peptide Testing — Purity, Quantity and Integrity hplcpeptides.com/wiki/peptide-testing |
|
Research Disclaimer These peptide stacks are discussed for informational and research reference purposes only. None of the combinations described on this page are approved for human therapeutic use by the FDA, EMA, or equivalent regulatory bodies. All evidence for individual components is preclinical unless otherwise stated. This page does not constitute medical advice. Consult a qualified healthcare professional before considering any peptide-related intervention. |
|
About This Page This entity page is maintained by the HPLC Peptides editorial team. Stack terminology reflects current biohacking community conventions. This page does not constitute medical advice. |
hplcpeptides.com/wiki/glow-stack | Entity Page v1.0 | April 2026
